First changed noticed of Feb. 26 PR. Noticed so

First changed noticed of Feb. 26 PR.

Noticed someone just updated the Board Information page. What's going on

Here's also a subtle change.

MARCH 08, 2018 - Elto Pharma Receives Notice of Allowance in Australia for Patent Covering Eltoprazine in the Treatment of Parkinson's Levodopa-induced Dyskinesia

Quote:

---

Elto Pharma is in the process of recruiting seasoned management to lead Elto Pharma going forward .

---

https://www.amarantus.com/news/press-releases...tralia-for

MARCH 05, 2018 - Elto Pharma to Present and Participate in Neuroscience Panel at Sachs BioCapital USA Forum

Quote:

---

"Sachs BioCapital USA Forum is an ideal venue for Elto Pharma to engage with the investment and partnering community," said Gerald Commissiong, interim-CEO of Elto Pharma .

---

https://ir.amarantus.com/press-releases/detai...uroscience

FEBRUARY 26, 2018
Amarantus Enters into Definitive Agreements for up to $1.5 Million in Funding

Quote:

---

"Concurrent with this announcement, the Company's CEO will be presenting an overview of Elto Pharma's pending Phase 2b Eltoprazine program for Parkinson's disease levodopa-induced dyskinesia (PD-LID) and Cutanogen Corporation's pending pivotal trial in Pediatric Severe Burns on Thursday March 1st, 2018 at 9:45pa ET at the BIOCOM Global Life Science Partnering Conference in San Diego, CA."

---